CAMLINFINESpecialty Chemicals
Camlin Fine Sciences Ltd — Cash Flow Statement
₹96.93
-6.09%
Camlin Fine Sciences Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -15.72 Cr | 78.41 Cr | -93.41 Cr | -68.34 Cr | — |
| Issuance Of Capital Stock | 223.13 Cr | 0.58 Cr | 0.55 Cr | 94.84 Cr | — |
| Capital Expenditure | -42.45 Cr | -60.58 Cr | -144.31 Cr | -213.79 Cr | — |
| End Cash Position | 104.07 Cr | 80.25 Cr | 93.74 Cr | 107.81 Cr | — |
| Other Cash Adjustment Outside Changein Cash | -1000.00 | — | 1000.00 | — | — |
| Beginning Cash Position | 80.25 Cr | 93.74 Cr | 107.81 Cr | 75.52 Cr | — |
| Changes In Cash | 23.82 Cr | -13.49 Cr | -14.07 Cr | 32.29 Cr | — |
| Financing Cash Flow | 72.44 Cr | -85.97 Cr | 59.66 Cr | 135.97 Cr | — |
| Interest Paid Cff | -69.61 Cr | -72.78 Cr | -51.94 Cr | -25.40 Cr | — |
| Preferred Stock Dividend Paid | 0.00 | -28.13 Cr | -13.85 Cr | -0.71 Cr | — |
| Net Common Stock Issuance | 223.13 Cr | 0.58 Cr | 0.55 Cr | 94.84 Cr | — |
| Common Stock Issuance | 223.13 Cr | 0.58 Cr | 0.55 Cr | 94.84 Cr | — |
| Net Issuance Payments Of Debt | -70.57 Cr | 25.21 Cr | 133.12 Cr | 76.06 Cr | — |
| Net Short Term Debt Issuance | -14.54 Cr | 0.18 Cr | 52.27 Cr | -29.71 Cr | — |
| Net Long Term Debt Issuance | -56.03 Cr | 25.03 Cr | 80.84 Cr | 105.77 Cr | — |
| Investing Cash Flow | -75.35 Cr | -66.50 Cr | -124.63 Cr | -249.13 Cr | — |
| Interest Received Cfi | 0.86 Cr | 1.23 Cr | 0.73 Cr | 1.70 Cr | — |
| Dividends Received Cfi | 0.82 Cr | 0.00 | — | — | — |
| Net Investment Purchase And Sale | -34.58 Cr | -7.71 Cr | 28.11 Cr | 28.50 Cr | — |
| Net PPE Purchase And Sale | -42.45 Cr | -60.02 Cr | -143.41 Cr | -213.79 Cr | — |
| Sale Of PPE | 0.00 | 0.56 Cr | 0.90 Cr | 0.00 | — |
| Purchase Of PPE | -42.45 Cr | -60.58 Cr | -144.31 Cr | -213.79 Cr | — |
| Operating Cash Flow | 26.72 Cr | 138.98 Cr | 50.90 Cr | 145.45 Cr | — |
| Taxes Refund Paid | -38.17 Cr | -47.53 Cr | -20.20 Cr | -30.37 Cr | — |
| Change In Working Capital | -78.42 Cr | 31.67 Cr | -138.79 Cr | 4.17 Cr | — |
| Change In Other Current Liabilities | -7.11 Cr | -10.18 Cr | 36.68 Cr | 92.72 Cr | — |
| Change In Other Current Assets | -71.31 Cr | 41.86 Cr | -175.47 Cr | -88.55 Cr | — |
| Other Non Cash Items | 92.65 Cr | 57.92 Cr | 40.35 Cr | 29.47 Cr | — |
| Stock Based Compensation | 0.28 Cr | 90000.00 | 2.36 Cr | 7.39 Cr | — |
| Provisionand Write Offof Assets | 2.07 Cr | -1.95 Cr | 4.54 Cr | -2.53 Cr | — |
| Depreciation And Amortization | 73.67 Cr | 78.61 Cr | 62.51 Cr | 55.96 Cr | — |
| Depreciation | 73.67 Cr | 76.86 Cr | 59.76 Cr | 52.80 Cr | — |
| Pension And Employee Benefit Expense | 2.53 Cr | 5.07 Cr | 2.51 Cr | 2.30 Cr | — |
| Gain Loss On Investment Securities | -7.49 Cr | -4.70 Cr | -0.30 Cr | -3.30 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 25.77 Cr | 32.37 Cr | 7.79 Cr | -11.99 Cr | — |
| Gain Loss On Sale Of PPE | 2.95 Cr | 0.15 Cr | 0.06 Cr | 0.23 Cr | — |
| Net Income From Continuing Operations | -158.05 Cr | -99.24 Cr | 80.38 Cr | 93.98 Cr | — |
| Cash Dividends Paid | — | -28.13 Cr | -13.85 Cr | -0.71 Cr | -5.42 Cr |
| Amortization Cash Flow | — | 1.74 Cr | 2.75 Cr | 3.16 Cr | 3.01 Cr |
| Net Business Purchase And Sale | — | — | 0.00 | -65.54 Cr | 0.00 |
| Purchase Of Business | — | — | 0.00 | -65.54 Cr | 0.00 |
| Net Other Financing Charges | — | — | — | -0.71 Cr | -5.42 Cr |
| Common Stock Dividend Paid | — | — | — | — | -5.42 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Camlin Fine Sciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.